• To ensure your request is directed to the right business and data integration team, please ensure you complete all the questions on the application form as fully as possible. 
  • Once you have spoken to a member of the business team, MIMS Australia will send you a Mutual Non-Disclosure Agreement (MNDA) and provide more information to help you understand the process for access and evaluation of the data.
  • There is an initial AUD 5,500.00 (incl gst) integration / conformance fee for all partner applicants for MIMS technical and clinical assistance with integrating the MIMS Medicines Database into a third-party application. This will be charged prior to you being provided with access to any of the MIMS data and is non-refundable. Your relevant BDM will be happy to discuss this further.
  • Please read the MNDA documents carefully then sign and return a scanned copy of the NDA marked to the attention of: Your relevant Business Development Manager (BDM).
  • Once the NDA has been returned and the developers fee paid, we will introduce you to our Solutions Delivery/ Data Integration Team, to provide you to access our test data. This team will organise a workshop to discuss the MIMS data base in detail, gather your integration requirements and help with any issues or concerns you may have. The team will also stay in touch throughout your development to support you through the process, and guide on how to best integrate the data.
  • Permission for use of the MIMS data base is granted for 6 months. After this six-month period if we have not heard from you, your access will be terminated. If you require access for a longer period, you will need to apply for an extension by contacting your BDM.
  • During your development your BDM will be working with you or your nominated business contact to agree on commercials and licensing of the MIMS data. Once the MNDA has been signed by both parties we are happy to discuss the commercials and advise you of this before you start the development. It is your responsibility to ensure you fully understand our fee structure and how it fits into your business model.
  • The provision of ongoing Monthly updated MIMS data is contingent on two important steps that must be taken prior to deployment of your final integration of our data base to your end users:
1. All licensing agreements and commercials between MIMS and your organisation must have been negotiated, agreed to and the Licence Agreement signed by both parties
2. The MIMS Data Team must review and approve the integration of MIMS data within your software.

Once everything has been completed you will be notified that approval to deploy your software with MIMS integrated is granted. 
 
MIMS Australia
Suite 3.02, 53 Berry Street
North Sydney 
NSW 2060
+61 2 9902 7700
www.mims.com.au
 

 

Question Title

1. Company Name

Question Title

2. ABN

Question Title

3. Address

Question Title

4. Postal Address if different from above

Question Title

5. 'Phone

Question Title

6. Company website

Question Title

7. Details of existing products and solutions

Question Title

8. Business contact

Question Title

9. Technical/Lead/Developer

Question Title

10. Is the developer employed with in your organisation

Question Title

11. If you are using an outside development team, please provide contact details

Question Title

12. Software Functionality? Please add all that apply

Question Title

13. Who are your intended user base? Please highlight all relevant options

Question Title

14. What is your intended platform and development environment?

Question Title

15. What type of application are you building? Please highlight all relevant options.

Question Title

16. What is your program language?

Question Title

17. What is your planned distribution method for MIMS monthly update to end users? Please highlight all relevant options:

Question Title

18. What is your intended user security for the MIMS monthly updates? Please add all that apply.

Question Title

19. Briefly describe the purpose of your software and how the MIMS data will be used in the software? Please also state how user (e.g. clinician) will be using the MIMS data in the software.

Question Title

20. What is the expected start date for integration of MIMS data?

Question Title

21. What is your expected launch date of your software with MIMS data.

Page1 / 1
 
100% of survey complete.

T